ClinicalTrials.Veeva

Menu

Epidemiology and Clinical Course of Pulmonary Embolism During and After Hospitalisation (REMATEV)

C

Centre Hospitalier Universitaire de Nice

Status

Completed

Conditions

Pulmonary Embolism

Treatments

Other: no intervention

Study type

Observational

Funder types

Other

Identifiers

NCT04980924
21cardio01

Details and patient eligibility

About

This survey will allow to identify PE prognostic, but also long-term complications, i.e. recurrence rate, on-treatment bleedings, deep-vein thrombosis sequella, pulmonary hypertension rate, and chronic pulmonary disease rate without PH. This database should help us identify risk-factors for each event.

Enrollment

547 patients

Sex

All

Ages

18 to 110 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All pulmonary embolisms hospitalised in Nice hospital.
  • acceptation to enter in the cohorte survey

Exclusion criteria

Trial design

547 participants in 2 patient groups

Pulmonary Embolism without reccurence or complication
Description:
Pulmonary Embolism without reccurence or complication
Treatment:
Other: no intervention
Pulmonary Embolism with reccurence or complication
Description:
Pulmonary Embolism with reccurence or complication, in particular occurrence of pulmonary hypertension.
Treatment:
Other: no intervention

Trial contacts and locations

1

Loading...

Central trial contact

emile Ferrari, PUPH; Amina Zamii-Smondel

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems